David J. King - Concepedia

Author

David J. King

University of Surrey ORCID

Also Known As

D King, D. J. King, D. King, D.J. KING, D.J. King, DAVID J. KING, David J King, David J. King, David King, King, D.

Publications

Citations

H-Index

Concepts

All Affiliations

University of Surrey The Pirbright Institute The University of Texas Medical Branch at Galveston University of California, San Francisco UK Health Security Agency

About

David J. King is an author at University of Surrey specializing in medicine, biochemistry, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	357
2	Natural Sciences	7	7	189
3	Biochemistry	7	7	189
4	Chemical Biology	2	2	38
5	Epidemiology	2	2	203

David J. King

Publications

903

Citations

H-Index

Page 1

	Year	Citations
APOBEC3 deaminase editing in mpox virus as evidence for sustained human transmission since at least 2016 Áine O’Toole, Richard A. Neher, Nnaemeka Ndodo, Science Viral ReplicationViral Polymerase MechanismPathologyCovid-19Pathogen Discovery	2023	180
Novel Combinatorial Selection of Phosphorothioate Oligonucleotide Aptamers David J. King, Daniel A. Ventura, Allan R. Brasier, Biochemistry	1998	97
A universal protocol to generate consensus level genome sequences for foot-and-mouth disease virus and other positive-sense polyadenylated RNA viruses using the Illumina MiSeq G. Logan, Graham Freimanis, David J. King, BMC Genomics	2014	84
Distinct monkeypox virus lineages co-circulating in humans before 2022 Nnaemeka Ndodo, Jonathan Ashcroft, Kuiama Lewandowski, Nature Medicine	2023	75
Combinatorial Selection and Binding of Phosphorothioate Aptamers Targeting Human NF-κB RelA(p65) and p50 David J. King, Suzanne E. Bassett, Xin Li, Biochemistry	2002	68
Distinguishing low frequency mutations from RT-PCR and sequence errors in viral deep sequencing data Richard Orton, Caroline F. Wright, Marco J. Morelli, BMC Genomics	2015	62
Thioaptamer Interactions with Prion Proteins: Sequence-specific and Non-specific Binding Sites David J. King, Jiri Safar, Giuseppe Legname, Journal of Molecular Biology Signal TransductionBiochemistryNatural SciencesMolecular BiologyPrion Disease	2007	49
Human prions and plasma lipoproteins Jiri Safar, Holger Wille, Michael D. Geschwind, Proceedings of the National Academy of Sciences Proteinlipid InteractionPrecursor PrpNative PrpCreutzfeldt-jakob DiseaseBiochemistry	2006	46
CD10 is a key enzyme involved in the activation of tumor-activated peptide prodrug CPI-0004Na and novel analogues: implications for the design of novel peptide prodrugs for the therapy of CD10+ tumors. Chin Pan, Pina M. Cardarelli, Matthew Nieder, PubMed Tumor EnvironmentPeptide EngineeringImmunologyNovel AnaloguesPeptide Therapeutics	2003	29
Efficacy of a high-potency multivalent foot-and-mouth disease virus vaccine in cattle against heterologous challenge with a field virus from the emerging A/ASIA/G-VII lineage Ryan Waters, Anna B. Ludi, Veronica L. Fowler, Vaccine	2018	29

Page 1